This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

Pfizer ($PFE) grabbed investors’ attention after signing a pricing agreement with the Trump administration. Meanwhile, analysts have responded ...

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the September 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...

Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...

Pfizer's revenue has stabilized, and a recent drug pricing deal with the US government reduces political uncertainty. Find ...

Pfizer, Inc. CEO Albert Bourla said on Tuesday that the U.S. pharmaceutical industry should work more collaboratively with ...

Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the August 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...

Pfizer is one of the world's largest and oldest drug companies. Thanks to its Covid vaccine, shares rose dramatically during the pandemic. Now that the stock has sharply corrected, long-term investors ...

Pfizer will reduce prices on drugs sold to Medicare patients. The Trump administration has made cutting prescription drug prices a priority. Ultimately, the administration aims to have Americans ...

Pfizer Inc. (NYSE:PFE) on Monday agreed to acquire Metsera, Inc. (NASDAQ:MTSR) to accelerate the next generation of medicines for obesity and cardiometabolic diseases. The acquisition brings a ...